STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells

Simon P. Newman, Paul A. Foster, Chloe Stengel, Joanna M. Day, Yaik T. Ho, Jean-Gabriel Judde, Myriam Lassalle, Gregoire Prevost, Mathew P. Leese, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Research output: Contribution to journalArticle

43 Citations (Scopus)
Original languageEnglish
Pages (from-to)597-606
JournalClinical Cancer Research
Volume14
Issue number2
DOIs
Publication statusPublished - 15 Jan 2008

Cite this

Newman, S. P., Foster, P. A., Stengel, C., Day, J. M., Ho, Y. T., Judde, J-G., Lassalle, M., Prevost, G., Leese, M. P., Potter, B. V. L., Reed, M. J., & Purohit, A. (2008). STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells. Clinical Cancer Research, 14(2), 597-606. https://doi.org/10.1158/1078-0432.CCR-07-1717